Growth & Venture
  • LinkedIn
  • Twitter
  • Companies
    • Technology
    • Healthcare & Life Sciences
    • Growth Products & Services
    • A-Z List of Investments
  • How We Help
  • Team
    • View by Location/Role
    • A-Z List of Team Members
  • About
  • News
  • LinkedInTwitter
Credit
  • About
  • Approach
  • Team
Public Equity
  • About
  • Approach
  • Team
Life@Summit
Inspiration, ideas and insights for growth companies: View Resource Center >
Summit Partners
Growth & Venture
  • LinkedIn
  • Twitter
  • Companies
    • Technology
    • Healthcare & Life Sciences
    • Growth Products & Services
    • A-Z List of Investments
  • How We Help
  • Team
    • View by Location/Role
    • A-Z List of Team Members
  • About
  • News
  • LinkedInTwitter
Credit
  • About
  • Approach
  • Team
Public Equity
  • About
  • Approach
  • Team
Life@Summit
Team Members

THE SUMMIT TEAM

Davide Molho, DVMExecutive-in-Residence

Email: Davide Molho, DVM

Select Investments:
  • Viroclinics Biosciences

As an Executive-in-Residence at Summit Partners, Davide works alongside Summit’s healthcare & life sciences team to identify new investment opportunities and advise growth stage companies focused on the development and commercialization of advanced therapies.

Davide brings more than 25 years of international operational and business management experience in the contract research organization (CRO), life sciences, biotechnology and animal health industries. He joins Summit Partners’ EIR program from Viroclinics-DDL, a Summit-backed virology and immunology contract research organization (CRO), where he had served as CEO since 2020. During his tenure, Davide led Viroclinics-DDL through a period of significant growth and global expansion, culminating in the company’s sale to Cerba Healthcare in 2022. Prior to Viroclinics-DDL, Davide served as CEO of Evolution Research Group and spent nearly two decades with Charles River Laboratories, where he held both commercial and operational roles, including serving as President and Chief Operating Officer of the global organization.

Davide holds a Doctor of Veterinary Medicine from The University of Milan and an Advanced Management Program Certificate of Harvard Business School.

Select Investments:
  • Viroclinics Biosciences
Related News
Summit News Artboard 1
November 10, 2022

CRO Industry Leader Davide Molho Joins Summit Partners as Executive-in-Residence

Portfolio News portfolio news icon Created using Figma
December 16, 2021

Cerba Healthcare to Acquire Viroclinics-DDL Expanding and Transforming Its Offering in Cl...

Cerba Healthcare to Acquire Viroclinics-DDL
Insights & Interests insights icon

Healthcare Trends: How Viroclinics-DDL is Accelerating the Development of Antiviral Thera...

Summit Partners Viroclinics
Growth Equity for Exceptional Companies
    • © 2023 Summit Partners. All rights reserved.

    • Privacy
    • Legal Disclosures
    • Sitemap
    • Cookie Settings
    • Contact Summit Partners
    • LP Login
    • Portfolio Company Careers
    • Join Our Newsletter